论文部分内容阅读
目的对超选择插管在胆管细胞型肝癌介入治疗中的应用价值进行分析。方法将2015年3月~2017年2月胆管细胞型肝癌患者48例随机分两组。非超选择组采用非超选择插管进行肝癌介入治疗,超选择组采用超选择插管进行肝癌介入治疗。比较两组患者胆管细胞型肝癌治疗总有效率;治疗前后血清AFP水平;治疗前和治疗后患者肝功能相关指标的差异。结果超选择组患者胆管细胞型肝癌治疗总有效率高于非超选择组(P<0.05);治疗前两组血清AFP水平比较无显著差异;治疗后超选择组血清AFP水平改善幅度更大(P<0.05)。治疗前两组肝功能相关指标比较无显著差异;治疗后超选择组肝功能相关指标变化更小(P<0.05)。结论超选择插管在胆管细胞型肝癌介入治疗中的应用价值高,可有效改善患者血清学指标,对肝功能损伤小,对患者预后有益,值得推广应用。
Objective To analyze the value of superselective intubation in interventional therapy of cholangiocarcinoma. Methods From March 2015 to February 2017, 48 patients with cholangiocellular carcinoma were randomly divided into two groups. Non-superadditive selection of non-superselective intubation of liver cancer interventional treatment, super-selection group using super-selective intubation of liver cancer interventional therapy. The total effective rate of treatment of cholangiocarcinoma in both groups was compared; the level of serum AFP before and after treatment; the difference of liver function related indexes before and after treatment. Results The total effective rate of cholangiocarcinoma in super-selection group was higher than that in non-super-selection group (P <0.05). There was no significant difference in serum AFP level between the two groups before treatment P <0.05). There was no significant difference between the two groups before the treatment of liver function related indicators; after treatment, the changes of liver function index in the super-selection group was smaller (P <0.05). Conclusion Superselective intubation in the treatment of cholangiocarcinoma hepatocellular carcinoma high value, which can effectively improve the patient’s serum markers, less damage to liver function, the prognosis of patients is worthy of promotion.